37005-77-9Relevant academic research and scientific papers
MODULATORS OF FARNESOID X RECEPTOR AND METHODS FOR THE USE THEREOF
-
Page/Page column 7; 10, (2016/08/17)
Compounds, compositions and methods are provided for treating the FXR-mediated disease or process in a mammal, comprising administering to the mammal a therapeutically effective amount of a compound claimed, wherein the FXR-mediated disease or condition linked to chronic liver diseases such as nonalcoholic fatty liver disease and nonalcoholic steatohepatitis; gastrointestinal diseases; cardiovascular diseases; metabolic diseases such as diabetes and obesity; inflammation, or cancer etc..
